Theory of mind and executive dysfunction in chronic inflammatory demyelinating polyneuropathy. [PDF]
Lochmann H+4 more
europepmc +1 more source
Corrigendum: Case report: Chronic inflammatory demyelinating polyneuropathy superimposed on Charcot-Marie-tooth type 1A disease after SARS-CoV-2 vaccination and COVID-19 infection. [PDF]
Li D, Yu H, Zhou M, Fan W, Guan Q, Li L.
europepmc +1 more source
Acute-onset chronic inflammatory demyelinating polyneuropathy following AstraZeneca COVID-19 vaccine: a case report. [PDF]
Smaoui E+7 more
europepmc +1 more source
Subcutaneous IgG for chronic inflammatory demyelinating polyneuropathy
openaire +4 more sources
Chronic Inflammatory Demyelinating Polyneuropathy as the Initial Presentation of Systemic Lupus Erythematosus Successfully Treated With Cyclophosphamide. [PDF]
Sastre Martínez AD+3 more
europepmc +1 more source
Deep Brain Stimulation Leads to Long-term Improvement of Neuropathic Tremor due to Chronic Inflammatory Demyelinating Polyneuropathy: A Case Report. [PDF]
Ujihara M+5 more
europepmc +1 more source
Lower extremity peripheral nerve block for total knee arthroplasty in a patient with chronic inflammatory demyelinating polyneuropathy: A case report. [PDF]
Nakamura Inaba A, Ishida Y, Toba Y.
europepmc +1 more source
Chronic inflammatory demyelinating polyneuropathy [PDF]
Treatment of chronic inflammatory demyelinating polyneuropathy (CIDP) requires long-term immunomodulatory therapy, which has potential side effects. Before such therapy is instituted, a firm diagnosis of CIDP must be established. Prednisone, plasma exchange (PE), and intravenous immunoglobulin (IVIG) are all proven first-line therapies for CIDP that ...
David S. Saperstein, Jonathan S. Katz
openaire +3 more sources
Immunoglobulins in chronic inflammatory demyelinating polyneuropathy [PDF]
This article reviews the efficacy and tolerability of intravenous immunoglobulins (IVIg) in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), including those forms associated with monoclonal gammopathy (paraproteinemic demyelinating neuropathy, PDN). Class I trials demonstrated that IVIg are effective in CIDP.
COMI , GIANCARLO+3 more
openaire +3 more sources